Observational studyJournal of neurology, neurosurgery, and psychiatry2026

Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity.

Franz Felix Konen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.